| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |